Dr. Rodgers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1950 Circle Of Hope Dr
Salt Lake City, UT 84112Phone+1 801-581-2121- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1979 - 1982
- Baylor College of MedicineResidency, Internal Medicine, 1976 - 1979
- Tulane University School of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1978 - Present
- UT State Medical License 1988 - 2026
- FL State Medical License 2014 - 2022
- LA State Medical License 1976 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Hematology
Clinical Trials
- A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Start of enrollment: 2014 Jul 14
Publications & Presentations
PubMed
- Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study.Simonsen, S., Lim, M., Rodgers, G., Branch, D.> ;Haemophilia. 2024 Mar 1
- Antithrombin Therapy: Current State and Future Outlook.George M Rodgers, Arash Mahajerin> ;Clinical and Applied Thrombosis/hemostasis. 2023 Oct 12
- Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura.George M Rodgers, Misa Berndt, Megan Fonteno, Jeffrey A Gilreath> ;Journal of Blood Medicine. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialGeorge M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Pharmacoeconomic Analysis of Ideal Vs. Actual Body Weight-Based Treatment for Adult Persons with Hemophilia _Clinically Relevant AbstractGeorge M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- UCLA Jonsson Comprehensive Cancer Center Researchers at ASH 2021 Annual Meeting and ExpositionDecember 14th, 2021
- (Epoetin Alfa-Epbx) Approved by U.S. FDAMay 15th, 2018
Grant Support
- Efficacy Of Enoxaparin In Trealment Of Deep Vein ThrombosisNational Center For Research Resources1995–1996
- Regulation Of Coagulation By Vascular CellsNational Heart, Lung, And Blood Institute1985–1986
- Nhlbi Clinical Investigator Award ProgramNational Heart, Lung, And Blood Institute1985–1986
Hospital Affiliations
- University of Utah HealthSalt Lake City, Utah
- George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: